Report Detail

Request for Sample of this report

Other Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2866984
    • |
  • 04 February, 2019
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

Scope of the Report:
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for ICAD (Intracranial Atherosclerotic Disease) Pathology is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 220 million US$ in 2024, from 130 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Stryker
Balt
TERUMO
MicroPort
Acandis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
primarily split into
Stent
PTA Balloon

Market Segment by Applications, can be divided into
Hospital
Clinic
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, with price, sales, revenue and global market share of ICAD (Intracranial Atherosclerotic Disease) Pathology in 2017 and 2018.
Chapter 3, the ICAD (Intracranial Atherosclerotic Disease) Pathology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ICAD (Intracranial Atherosclerotic Disease) Pathology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, ICAD (Intracranial Atherosclerotic Disease) Pathology market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 primarily split into
      • 1.2.2 Stent
      • 1.2.3 PTA Balloon
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Clinic
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Stryker
      • 2.1.1 Business Overview
      • 2.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Balt
      • 2.2.1 Business Overview
      • 2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 TERUMO
      • 2.3.1 Business Overview
      • 2.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 MicroPort
      • 2.4.1 Business Overview
      • 2.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Acandis
      • 2.5.1 Business Overview
      • 2.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2018
      • 3.3.2 Top 6 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis by Regions

    • 4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Regions
      • 4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 4.5 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Country

    • 5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Country
      • 5.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Country (2014-2019)
    • 5.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 5.3 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 5.4 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Country

    • 6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Country
      • 6.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 6.3 UK ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 6.4 France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 6.5 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 6.6 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Country

    • 7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Country (2014-2019)
    • 7.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 7.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 7.4 Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 7.5 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    8 South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Country

    • 8.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Country
      • 8.1.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 8.3 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 8.4 Colombia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    9 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries

    • 9.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 9.3 Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 9.4 Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)
    • 9.6 South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2014-2019)

    10 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Type

    • 10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2014-2019)
    • 10.2 primarily split into Sales Growth and Price
      • 10.2.1 Global primarily split into Sales Growth (2014-2019)
      • 10.2.2 Global primarily split into Price (2014-2019)
    • 10.3 Stent Sales Growth and Price
      • 10.3.1 Global Stent Sales Growth (2014-2019)
      • 10.3.2 Global Stent Price (2014-2019)
    • 10.4 PTA Balloon Sales Growth and Price
      • 10.4.1 Global PTA Balloon Sales Growth (2014-2019)
      • 10.4.2 Global PTA Balloon Price (2014-2019)

    11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application

    • 11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Clinic Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)

    • 12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions (2019-2024)
      • 12.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)
      • 12.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)
      • 12.2.4 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2019-2024)
    • 12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Type (2019-2024)
      • 12.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2019-2024)
      • 12.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Type (2019-2024)
    • 12.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Application (2019-2024)
      • 12.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2019-2024)
      • 12.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on ICAD (Intracranial Atherosclerotic Disease) Pathology . Industry analysis & Market Report on ICAD (Intracranial Atherosclerotic Disease) Pathology is a syndicated market report, published as Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,752.68
      		4,129.02
      		5,505.36
      		3,208.56
      		4,812.84
      		6,417.12
      		540,444.00
      		810,666.00
      		1,080,888.00
      		290,580.00
      		435,870.00
      		581,160.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo